Disclaimer: The information contained herein should NOT be used as a substitute for the advice of an appropriately qualified and licensed physician or other health care provider. The tool is not a substitute for the care provided… (more)
European journal of endocrinology • 2000 | View Paper
“Areas under the glucose and insulin curves during oral glucose tolerance testing were both approximately 30% lower after Acipimox administration than after placebo.”
“The short-term administration of a nicotinic acid analogue acipimox ) increases insulin sensitivity and consequently glucose disposal , both in patients with non-insulin-dependent diabetes mellitus (NIDDM) and in patients with cirrhosis.”
Metabolism: clinical and experimental • 1993 | View Paper
“ Acipimox blunted the … in glucose after oral glucose loading and decreased incremental glucose concentration (from 579 +/- 76 to 445 +/- 65 mmol/min/L, P less than .02) and incremental insulin concentration (from 13.4 +/- 2.5 to 9.0 +/- 1.4 U/min/L, P = .056) in the OGTT.”
Metabolism: clinical and experimental • 1992 | View Paper
“ Acipimox tended to increase glucose and decrease lipid utilization rates at the whole body level and significantly changed the effect of insulin on substrate utilization.”
American journal of physiology. Heart and circulatory physiology • 2010 | View Paper
“RESULTS Ba al glucose tu rnover was significantly reduced by addition of aci pimox (r ate of disappearance (Rd) glucose (mg/kg/min): 1.91+/-0.08 (expt.”
European journal of endocrinology • 2004 | View Paper
“Similar to CL-316243, Acipimox (150 mg/kg orally) markedly decreased plasma FFA, glucose , and insulin concentrations and improved glucose tolerance while reducing the insulin response in obese (350 to 400 g) ZDF rats.”